BackBioLineRx Overview

BioLineRx Current Assets

BioLineRx's current assets is $16M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$16.35M
↓ 48.69% YoYΔ $-15.51M vs prior year quarter

Peer trimmed avg / median

Loading

BioLineRx Current Assets History

Loading

BioLineRx vs. peers: Current Assets Comparison

Loading

BioLineRx Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioLineRx (BLRX.TA) FAQ

BioLineRx (BLRX.TA) currently reports a current assets of $16M as of June 2026. That compares with $32M in the prior-year period — down 48.7% year over year. Use the charts on this page to explore BioLineRx's current assets history and peer comparisons.

BioLineRx's current assets decreased from $32M to $16M — a 48.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioLineRx reported $16M in current assets as of June 2026. That compares with $32M in the prior-year period — down 48.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioLineRx, and consider following BLRX.TA for alerts when major investors trade the stock.

BioLineRx is classified in the Healthcare sector. On current assets, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BLRX.TA with unrelated industries.